^
Association details:
Biomarker:No biomarker
Cancer:Peripheral T-cell Lymphoma
Regimen:GemOx (gemcitabine + oxaliplatin)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Peripheral T-Cell Lymphomas...Combination regimens...GemOx (gemcitabine, oxaliplatin)